Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma - Concepedia

Concepedia

Publication | Closed Access

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma

83

Citations

21

References

2002

Year

Seema Singhal, R Powles, Bhawna Sirohi, J Treleaven, S Kulkarni, Jayesh Mehta

Bone Marrow Transplantation

Hematological MalignancySurvival BenefitMedicineImmunologyMetronomic ChemotherapyOncologyRadiation OncologyHigh-dose MelphalanInduction Chemotherapy

References

	Year	Citations

Page 1